February 16, 2018
On the heels of the budget deal reached last week in Congress, the CEOs of numerous scientific organizations temporarily celebrated, but recognized that the increase in the budget caps for Fiscal Years 2018 and 2019 would not necessarily translate into increases in science funding.
Early this week, Research America coordinated a letter among Science CEOs that thanked the House and Senate leadership (majority and minority), as well as the Chair and Ranking Members of the Appropriations Committees, for their “pivotal role” in finalizing a budget agreement to raise the caps on federal spending. The letter went further, however, and urged the leadership to ensure robust funding increases for federal science agencies. “Whether the objective is to stoke the engine of our economy, confront threats to the health and safety of Americans, or forge a path to long-term fiscal stability, strengthening investments in R&D will generate crucial returns to our nation,” the letter stated.
House and Senate leaders hope to finalize an omnibus spending bill for FY 2018 by March 23rd, the date the current temporary (stopgap) funding bill expires.
Read the entire letter: 02.15.2018 Science CEO Letter
FABBS Comments on the NIH Minority Health and Health Disparities Strategic Plan for 2026-2030